Newsletter/Booklets 7th Jul 2023

Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations

Authors

Parthsarathi JhaPartner | New Delhi | Noida
Sanjay NotaniPartner | Mumbai
Mitul KaushalConsultant | Delhi NCR
Harika BakarajuPrincipal Associate | Mumbai
Naghm GheiPrincipal Associate | Delhi NCR
Divyashree SuriSenior Associate | Delhi NCR

Latest Thought Leadership

Alerts & Updates 25th Sep 2026

Key decisions taken in the SEBI Board Meeting dated 24th September 2026

Read More
international trades
Alerts & Updates 24th Sep 2026

ELP Sanctions Update – Foreign Sanctions and Contractual Obligations: Delhi High Court Directs Resumption of SAP Support Services to Nayara Energy

Read More
Alerts & Updates 22nd Sep 2026

Sanctions Update – Lindsey O. Graham Sanctioning Russia and Iran Act of 2026 and Implications for India

Read More
international trades
Newsletter/Booklets 22nd Sep 2026

Trade Newsletter: August 2026

Read More

This report examines the regulatory environment of some of India’s key trading partners, with a view to identify existing and potential trade barriers in exporting pharmaceuticals in these markets.  This serves as a ready reckoner and comprehensive guide for the pharmaceutical industry.

Click here

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.